Johnson & Johnson COVID-19 vaccine authorized for emergency use in India
For this year the company, located in New Brunswick revenue will be around 94.44 billion USD. This is according to the average of the analysts' estimates. This is rather significant more than 2021's revenue of 82.58 billion USD.
Historical revenues and results Johnson & Johnson plus estimates 2021
The analysts expect for 2021 a net profit of 25.79 billion USD. The majority of the analysts expects for this year a profit per share of 9.67 USD. With this the price/earnings-ratio is 18.39.
Per share the analysts expect a dividend of 4.17 USD per share. The dividend yield is then 2.34 percent. The average dividend yield of the health care companies is a low 1.25 percent.
Latest estimates around 177 USD
The latest 3 recommendations for the health care company were provided by Credit Suisse , ABN AMRO and KBC Securities.Johnson & Johnson 's market capitalization is based on the number of outstanding shares around 468.17 billion USD. 23
Historical stock prices Johnson & Johnson period 2007-2021
At 19.28 the stock trades 0.39 percent higher at 177.84 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
